Press Releases - 2017

2017

 

2016

 

2015

 

2014

 

2013

 

 

11/17/17

 AMCP CEO Susan A. Cantrell, RPh, CAE Is Appointed to Pharmacy Quality Alliance Board of Directors  

 AMCP CEO Susan A. Cantrell, RPh, CAE has been appointed to the Pharmacy Quality Alliance (PQA) 2018-2019 Board of Directors.

11/2/17

AMCP Releases Proceedings on Advancing Value-Based Contracting, With Consensus Definitions, Strategies to Move Concept Forward 

Consensus document on value-based contracting includes a key stakeholder definition of VBC along with strategies to implement the innovative payment model.

10/27/17

AMCP Stakeholder Forum Identifies Pathway to Using Patient Reported Outcomes in Value-Based Health Care System  

AMCP Partnership Forum “Patient Reported Outcomes: The Missing Link to Defining Value” took place on Oct. 19, 2017.

10/20/17

AMCP Nexus 2017 Draws Nearly 2,500 Managed Care Pharmacy Professionals for Conference Themed 'Changing the Way We Pay for Health Care'  

Nearly 2,500 managed care pharmacy professionals from across the country gathered in the heart of Texas this week for dozens of educational sessions and discussions on how to boost outcomes and control costs for the roughly 270 million Americans covered by a managed pharmacy benefit.

10/19/17

AMCP's "America's Pipeline Conundrum: Paying for Cures" Panel Examines Gene Therapy Reimbursement Challenges 

Four leading health care experts are generally optimistic that the U.S. will successfully address one of the fiercest challenges facing the health care system: paying for often spectacular, but high-cost gene and other curative therapies.

10/19/17

AMCP Foundation 7th Annual Research Symposium Examines Benefits of Value-Based Health Care From Multiple Stakeholder Perspectives 

The perception of what is "valuable" in any particular therapy can vary widely between providers, patients and payers, according to panelists at the Academy of Managed Care Pharmacy (AMCP) Foundation's 7th Annual Research Symposium.

10/6/17

AMCP Foundation and Allergan Offered Summer Internships in Managed Care Pharmacy 

The AMCP Foundation is delighted to announce that two student pharmacists recently completed a summer internship organized by the Foundation and supported by Allergan Plc.

10/6/17

AMCP Foundation and Genentech Offered Summer Internships in Managed Care Pharmacy  

The AMCP Foundation is delighted to announce that two student pharmacists recently completed a summer internship organized by the Foundation and supported by Genentech, Inc.

10/6/17

 AMCP Foundation and Pfizer Offered Eight Summer Internships in Managed Care Pharmacy 

The AMCP Foundation is delighted to announce that eight student pharmacists from across the country recently completed summer internship programs organized by the Foundation and supported by Pfizer, Inc.

9/28/17

Value-Based Health Care Headlines National Pharmacy Meeting in Dallas 

Managed Care Pharmacists to Address “Changing the Way We Pay for Health Care” – Including Benefits to Patients, Payers and Providers and Gene Therapy Reimbursement

8/14/17

Lowering Cost Share May Improve Rates of Home Glucose Monitoring Among Patients with Diabetes Using Insulin, According to JMCP Article    

Lowering the out-of-pocket costs of blood glucose testing strips can improve diabetes patients’ persistence with home monitoring, according to an article in the August 2017 issue of the Journal of Managed Care & Specialty Pharmacy (JMCP).  

8/2/17

New York Times Article on Value-Based Contracting Doesn’t Tell Full Story, Says Academy of Managed Care Pharmacy 

Conclusions reached in a recent New York Times article on outcomes-based contracting are premature, if not inaccurate, stated Academy of Managed Care Pharmacy (AMCP) CEO Susan A. Cantrell, RPh, CAE

7/13/17

Statement from AMCP CEO Susan A. Cantrell, RPh CAE, on House Passage of FDARA 

AMCP commends the House for its passage yesterday of H.R. 2430, the Food and Drug Administration Reauthorization Act (FDARA) of 2017. 

7/12/17

AMCP-Supported Bill to Create Safe Harbor for Pre-FDA-Approval Product Communications Examined in House Subcommittee on Health Hearing 

Washington, D.C., July 12, 2017 — The U.S. House Energy and Commerce Committee’s Subcommittee on Health held a hearing today on the “Pharmaceutical Information Exchange (PIE) Act of 2017” (H.R. 2026). 

6/23/17

AMCP Partnership Forum Attendees Create Action Plans to Advance Value-Based Contracting

Diverse stakeholders representing managed care pharmacy, provider groups, integrated delivery systems and the biopharmaceutical industry this week developed key strategies to enable the expansion of “value-based contracting.”

6/7/17

Cantrell Comments on House Energy & Commerce Committee Action on PIE Act  

Pre-FDA-approval communications took an important step forward in today’s discussion of H.R. 2026. 

6/5/17

Journal of Managed Care & Specialty Pharmacy Supplement Examines Frameworks for Assessing Value of Oncology Treatments 

To address escalating drug costs, health care payers increasingly are adopting benefit designs that aim to identify and pay for medications based on their value. The June issue of the Journal of Managed Care & Specialty Pharmacy features a special supplement comparing existing “value frameworks” used in such benefit designs to assess high-cost oncology treatments. 

5/1/17

AMCP Releases Multi-Stakeholder Findings to Drive Value and Outcomes in Oncology 

Increased collaboration, improved decision-making support tools and greater use of value-based contracting are among the recommendations to address the accelerating pace of oncology products coming to market each year, according to proceedings from the AMCP Partnership Forum: Driving Value and Outcomes in Oncology

4/28/17

AMCP Foundation Holds Successful Campaigns to Support Future Research, Help Low-Income Residents in Denver 

The AMCP Foundation fulfilled a significant part of its philanthropic mission last month with two successful giving campaigns.

4/26/17

JMCP Research Highlight: Hypoclycemia, A1C Control, and Adherence Affect Costs for Patients with Type 2 Diabetes in a Real-World Population 

While improved adherence to diabetes medications is associated with higher drug costs, it also is associated with lower inpatient, outpatient and emergency room costs, according to a study in this month’s

4/10/17

AMCP Applauds Introduction of the “Pharmaceutical Information Exchange (PIE) Act of 2017” 

 The Academy commends Rep. Brett Guthrie (R-KY) for introducing H.R.2026, the "Pharmaceutical Information Exchange (PIE) Act of 2017."

3/30/17

AMCP Foundation Announces Recipients of 2017 National P&T Competition, Best Poster Contests 

Denver, Colo., March 30, 2017 — The AMCP Foundation is proud to announce winners of its 17th Annual National Student Pharmacist Pharmacy & Therapeutics (P&T) Competition and 2017 Best Poster Contests for student pharmacists, residents or fellows, and graduate students. Winning the P&T Competition was the University of North Carolina Eshelman School of Pharmacy. Winner of the Best Student Pharmacist Poster was Arianna Kee; Best Resident or Fellow Poster was Kameron Kelly, PharmD; and Best Graduate Student Poster was Sanket Shah, MBBS.

3/30/17

AMCP Foundation Board of Trustees Swears in New Member, Summerpal Kahlon, MD

Denver, Colo., March 30, 2017 — The Academy of Managed Care Pharmacy (AMCP) Foundation is pleased to announce the addition of Summerpal Kahlon, MD, to its Board of Trustees.

3/30/17

Managed Care Pharmacy Leaders Honored at Academy of Managed Care Pharmacy/AMCP Foundation Awards Dinner

Denver, Colo., March 30, 2017 — The Academy of Managed Care Pharmacy and AMCP Foundation honored some of managed care pharmacy’s brightest leaders last night at the Annual Award Dinner. Eight awards were presented at the gala event held March 29 as part of the AMCP Managed Care & Specialty Pharmacy Annual Meeting in Denver, Colorado.

3/28/17

Academy of Managed Care Pharmacy Opens AMCP Managed Care & Specialty Pharmacy Annual Meeting

Denver, Colorado, March 28, 2017 — Four thousand managed care pharmacy professionals and stakeholders from across the country have traveled to Denver, Colorado, this week for the Academy of Managed Care Pharmacy (AMCP) Managed Care & Specialty Pharmacy Annual Meeting.

3/8/17

AMCP Members Urge Congress, Administration to Include Comprehensive Pharmacy Benefit in Reform Plan 

Managed care pharmacy professionals have the expertise necessary to help lawmakers develop policies for an effective pharmaceutical benefit under any new health care reform bill that may emerge in the weeks and months ahead. That was the key message delivered over the past two days by the Academy of Managed Care Pharmacy (AMCP) at its Annual Legislative Days.

2/23/17

AMCP Foundation Executive Director Paula Eichenbrenner Named ‘Young & Aspiring’ Association Executive by Association TRENDS Magazine   

Eichenbrenner was one of five individuals selected for this prestigious national award, presented since 1998 to the brightest rising stars of the association community. 

2/3/17

This Month’s Journal of Managed Care & Specialty Pharmacy Focuses on Optimizing Outcomes in Oncology 

February’s themed issue of the Journal of Managed Care & Specialty Pharmacy examines challenges that managed care pharmacists face in administering oncology therapies, including considerations around patient-reported outcomes and the role of caregivers.

1/25/17

Biologics & Biosimilars Collective Intelligence Consortium (BBCIC) Announces Addition of Apobiologix to Consortium

The Biologics & Biosimilars Collective Intelligence Consortium (BBCIC) is pleased to announce the addition of a new participating organization, Apobiologix.

1/18/17

AMCP Praises FDA’s Guidance on Communications Between Biopharmaceutical Companies and Population Health Decision Makers; Guidance Largely Aligns With AMCP Recommendations  

The Academy commends the FDA for its release today of draft guidance clarifying how biopharmaceutical companies and population health decision makers can proactively share clinical and economic information on both FDA approved products as well as emerging therapies awaiting FDA approval. 

1/1/17

AMCP Releases Consensus Recommendations Proposing the Creation of a Safe Harbor for Preapproval Information Exchange (PIE)    

The Academy has released a set of consensus recommendations to allow biopharmaceutical companies to proactively share clinical and economic information with population health decision makers on emerging therapies in advance of FDA approval, an area that is significantly restricted by current federal laws and FDA regulations. 


 

Content for class "break" Goes Here